News | October 13, 2021
PCI Pharma Services acquires LSNE for its CDMO business
Transformational partnership establishes PCI as a CDMO and broadens capabilities across drug product lifecycle
Transformational partnership establishes PCI as a CDMO and broadens capabilities across drug product lifecycle
The company plans to raise US $ 15 million
This expansion will support the global operations network and help meet global demand for mammalian development services that support Lonza’s manufacturing sites
In Western Europe, about 2% of procedures are done robotically while the majority, approximately 65%, are open surgery
The test kit uses a reagent developed using Kaneka's molecular testing-related technologies
The injection is used to reverse the effects of the muscle relaxants given to patients during surgery
The rolling submission to the U.S. FDA will begin in the fourth quarter of this year
This opens up a huge market for the company’s Magnezis implants in India
Next-generation radiofrequency catheter offers first thermal ablation perforator treatment advancement in over 10 years
The company has already received the emergency use authorization (EUA) from the Drug Controller General of India (DCGI) for ZyCoV-D to be administered in three doses on August 20
Subscribe To Our Newsletter & Stay Updated
